Bezisterim (NE3107)

MedicationExperimental0 reviews

—

Average score out of 5

Experimental — This treatment is under research. Available data is limited. Consult your doctor before making any decision.

Bezisterim (NE3107) is an investigational drug that modulates inflammatory signaling. It is being studied for its potential to reduce neuroinflammation and cognitive symptoms (brain fog) in Long COVID.

Information

Subcategory: inflammation modulator
Evidence level: 2/5
Evidence type: randomized controlled trial (phase 2)

Share your experience

Your feedback helps thousands of people find what really works.

Join the community